INFLAMMATORY MYOPATHY
Clinical trials for INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cell therapy targets tough autoimmune cases
Disease control Recruiting nowThis early-stage study tests a new cell treatment called YTS109 in about 18 adults with autoimmune diseases like lupus or scleroderma that have not responded to standard therapies. Participants receive a single infusion of these modified immune cells. The main goal is to check sa…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:13 UTC
-
Revolutionary One-Shot CAR-T treatment targets lupus and more
Disease control Recruiting nowThis early-phase study tests a new therapy called TI-0032-III for people with severe autoimmune diseases like lupus that haven't responded to other treatments. The therapy uses a special injection to create cancer-fighting cells inside the body that target and destroy faulty immu…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated May 26, 2026 08:12 UTC
-
New cell therapy hopes to tame tough autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called YTS109 in 18 adults with severe autoimmune diseases like lupus and Sjogren's syndrome that have not responded to standard treatments. Participants receive a single infusion of these specially designed immune cells. The m…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
Experimental cell therapy takes on lupus and other autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a new cell therapy called YTS109 in 18 adults with hard-to-treat autoimmune diseases like lupus and Sjogren's syndrome. Participants receive a single infusion of these specially designed cells. The main goal is to see if the treatment is safe, and res…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:08 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called YTS109 in 18 adults with autoimmune diseases like lupus and Sjogren's syndrome that have not responded to standard treatments. Participants receive a single infusion of these immune cells to see if it is safe and can help con…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-stage study tests a universal CAR T-cell therapy designed to target and destroy certain immune cells (those with CD19 or BCMA markers) that drive autoimmune diseases. It enrolls 12 adults with severe conditions like lupus, scleroderma, or vasculitis that have not respo…
Matched conditions: INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Patients with rare muscle diseases help decide what scientists should study next
Knowledge-focused Recruiting nowThis study asks people with rare myositis diseases (like dermatomyositis or inclusion body myositis) and their caregivers what they think researchers should focus on. Through online surveys and forums, the goal is to create a list of patient-driven research priorities. The study …
Matched conditions: INFLAMMATORY MYOPATHY
Sponsor: Myositis International Health & Research Collaborative Alliance Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 08:13 UTC